Maria Bouzani

Athens, ESYE31, Greece

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece.

Management strategies for CAR-T cell therapy-related toxicities: results from a survey in Greece.

Journal: Frontiers in medicine

Published: December 31, 2024

Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment.

Greek Consensus on Chronic Lymphocytic Leukemia (CLL) Treatment.

Journal: Mediterranean journal of hematology and infectious diseases

Published: December 02, 2024

Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.

Clinical characteristics and outcome of early-stage diffuse large B cell lymphoma of female genital track: A retrospective study of the Hellenic cooperative lymphoma group.

Journal: Hematological oncology

Published: May 13, 2024

Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis.

Reply to: Differential diagnosis between Kaposi sarcoma-associated herpesvirus cytokine syndrome and hemophagocytic lymphohistiocytosis.

Journal: Infection

Published: April 03, 2024

EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy.

EASIX and m-EASIX predict severe cytokine release syndrome and overall survival after CAR T-cell therapy.

Journal: Blood vessels, thrombosis & hemostasis

Published: March 13, 2024

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.

Genetic Characterization of Primary Mediastinal B-Cell Lymphoma: Pathogenesis and Patient Outcomes.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 06, 2023

A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent.

A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent.

Journal: Infection

Published: November 05, 2023

PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?

PET for Response Assessment to R-da-EPOCH in Primary Mediastinal Large B-cell lymphoma: Who Is Worthy to be Irradiated?

Journal: HemaSphere

Published: April 24, 2023

Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Correction to: Cost‑Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Journal: Clinical drug investigation

Published: December 29, 2022

Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Cost-Utility Analysis of Pegaspargase for the Treatment of Acute Lymphoblastic Leukemia in Greece.

Journal: Clinical drug investigation

Published: September 26, 2022

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.

Real-life Experience With Rituximab-CHOP Every 21 or 14 Days in Primary Mediastinal Large B-cell Lymphoma.

Journal: In vivo (Athens, Greece)

Published: March 01, 2022

Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.

Real-life experience with the combination of polatuzumab vedotin, rituximab, and bendamustine in aggressive B-cell lymphomas.

Journal: Hematological oncology

Published: December 23, 2020

Showing 1-12 of 12

Last Updated: 09/26/2026